John Armitage's BSX Position Overview
John Armitage (via Egerton Capital (Uk) Llp) currently holds 5.3M shares of Boston Scientific Corporation (BSX) worth $518.66 M, representing 5.47% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Armitage has initiated a new position in BSX, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 3.7M shares.
Analysis based on 13F filings available since 2013 Q2
John Armitage's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by John Armitage
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +1.64 M | New Buy | 1.64 M | $107.41 |
| Q3 2025 | +3.67 M | Add 223.74% | 5.31 M | $97.63 |
John Armitage's Boston Scientific Corporation Investment FAQs
John Armitage first purchased Boston Scientific Corporation (BSX) in Q2 2025, acquiring 1,640,956 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage has held Boston Scientific Corporation (BSX) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage's largest addition to Boston Scientific Corporation (BSX) was in Q3 2025, adding 5,312,504 shares worth $518.66 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, John Armitage's firm, Egerton Capital (Uk) Llp, owns 5,312,504 shares of Boston Scientific Corporation (BSX), valued at approximately $518.66 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 5.47% of John Armitage's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage's peak holding in Boston Scientific Corporation (BSX) was 5,312,504 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.